Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DINAMO: Insulin Glargine + Glulisine vs NPH + Regular Insulin in T2DM with Renal Failure
NCT01122979Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2010
- Primary completion
- Oct 2013
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine, insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jul 2010; status: completed.
02
Drugs
insulin glargineinsulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01122979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01122979.